News

Pharmacy Services

Beginning January 1, 2018 there will be some formulary changes that will apply to Premier Health Plan’s commercial members – Premier Health Employee Plan and Premier Health Business Value Plan. 

The following drugs will be removed from the formulary:

Drug Name   Alternative  
FLUOCINONIDE 0.05  fluocinonide lotion and fluocinonide ointment
HYDROCODONE-ACETAMINOPHEN 5-300 MG  hydrocodone/acetaminophen 5mg/325mg, hydrocodone/acetaminophen 7.5mg/325mg, and hydrocodone/acetaminophen 10mg/325mg
NASONEX 50 MCG/ACT  fluticasone nasal spray, flunisolide nasal spray and Veramyst
DYMISTA 137-50 MCG/ACT  fluticasone nasal spray, flunisolide nasal spray and Veramyst
VICODIN ES 7.5-300 MG  hydrocodone/acetaminophen 5mg/325mg, hydrocodone/acetaminophen 7.5mg/325mg, and hydrocodone/acetaminophen 10mg/325mg
HYDROCODONE-ACETAMINOPHEN 7.5-300 MG  hydrocodone/acetaminophen 5mg/325mg, hydrocodone/acetaminophen 7.5mg/325mg, and hydrocodone/acetaminophen 10mg/325mg
QNASL 80 MCG/ACT  fluticasone nasal spray, flunisolide nasal spray and Veramyst

The following non-preferred drugs will have a higher tier cost share.  The alternative medications are preferred formulary medications:

Drug Name   Alternative  
QVAR 80 MCG/ACT  Asmanex or Flovent HFA
QVAR 40 MCG/ACT  Asmanex or Flovent HFA
BYDUREON 2 MG  Trulicity and Victoza
XOPENEX HFA 45 MCG/ACT  Ventolin HFA
TUDORZA PRESSAIR 400 MCG/ACT  Incruse Ellipta or Spiriva

Back to the December 2017 Issue